Strategic Real Estate Solutions Nationwide.
Brief biography - Denis Logunov
creators of the Sputnik vaccine
- Deputy Director for Scientific Work at the N. F. Gamaleya Center.
- Head of the Laboratory of Cellular Microbiology.
- Doctor of Biological Sciences (since 2011).
- Academician of the Russian Academy of Sciences (since 2022).
- Laureate of the State Prize of the Russian Federation in Science and Technology (2020).
Sputnik V COVID-19 vaccine
This interview features Denis Logunov, a principal developer of the Sputnik V COVID-19 vaccine. We will discuss the monumental scientific achievement of creating a safe, effective vaccine at unprecedented speed to combat a global pandemic. Sputnik V was crucial, immunizing millions worldwide and providing a pivotal tool in the fight against the virus. This conversation offers a unique window into the immense challenges, breakthrough innovations, and personal resolve behind one of modern medicine's most significant endeavors, highlighting the critical role of science in serving humanity during a crisis.
Safety and immunogenicity of a heterologous COVID-19 vaccine (rAd26/rAd5): phase 1/2 studies from Russia
Who prepared it:
The article was prepared by a group of Russian scientists from:
The article was prepared by a group of Russian scientists from:
- The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya (Ministry of Health of the Russian Federation),
- in collaboration with staff from Sechenov University and the Main Military Clinical Hospital named after N.N. Burdenko.